73 research outputs found
The effect of age, anatomical site and bone structure on osteogenesis in New Zealand White rabbit
Among animal models, rabbits are widely used in medical research, as they fill the gap between smaller models, commonly employed in basic science, and larger ones, which are better suited for preclinical trials. Given their rapid growth, rabbits provide a valuable system for the evaluation of bone implants for tissue regeneration. By means of a histomorphometric analysis, here we quantified the mineral apposition rates (MARs) in osteonic, periosteum and endosteum osteogenic fronts, of skeletal elements within femur, tibia, radius, ulna, frontal and parietal bones in New Zealand White rabbits aged 6, 7 and 8 months. Our hypothesis is that the MAR varies according to the skeletal maturity of the animal, and also within the skeletal elements and the osteogenic fronts considered. In the present study we show that the MAR in both femur and tibia is significantly higher than in ulna and radius. We also demonstrate that the MAR in parietal bones is significantly higher compared to the MAR of both frontal and forelimb bones. Contrary to what was expected, the MARs of all the skeletal elements considered were not decreased following full skeletal maturity. Finally, the MAR of the osteonic-osteogenic front is the lowest in all of the skeletal elements considered. In conclusion, these results provide new important insights for the evaluation of bone implants, casting a light on the role of both age and osteogenic fronts on the bone MAR, and providing valuable information on the physiological bone turnover in New Zealand White rabbits
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by the aberrant accumulation of extracellular matrix in the lungs. nintedanib is one of the two FDA-approved drugs for IPF treatment; however, the exact pathophysiological mechanisms of fibrosis progression and response to therapy are still poorly understood. In this work, the molecular fingerprint of fibrosis progression and response to nintedanib treatment have been investigated by mass spectrometry-based bottom-up proteomics in paraffin-embedded lung tissues from bleomycin-induced (BLM) pulmonary fibrosis mice. Our proteomics results unveiled that (i) samples clustered depending on the tissue fibrotic grade (mild, moderate, and severe) and not on the time course after BLM treatment; (ii) the dysregulation of different pathways involved in fibrosis progression such as the complement coagulation cascades, advanced glycation end products (AGEs) and their receptors (RAGEs) signaling, the extracellular matrix-receptor interaction, the regulation of actin cytoskeleton, and ribosomes; (iii) Coronin 1A (Coro1a) as the protein with the highest correlation when evaluating the progression of fibrosis, with an increased expression from mild to severe fibrosis; and (iv) a total of 10 differentially expressed proteins (padj-value ≤ 0.05 and Fold change ≤-1.5 or ≥1.5), whose abundance varied in the base of the severity of fibrosis (mild and moderate), were modulated by the antifibrotic treatment with nintedanib, reverting their trend. Notably, nintedanib significantly restored lactate dehydrogenase B (Ldhb) expression but not lactate dehydrogenase A (Ldha). Notwithstanding the need for further investigations to validate the roles of both Coro1a and Ldhb, our findings provide an extensive proteomic characterization with a strong relationship with histomorphometric measurements. These results unveil some biological processes in pulmonary fibrosis and drug-mediated fibrosis therapy
Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach
Cystic fibrosis (CF) is a multiorgan disease caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR). In addition to respiratory impairment due to mucus accumulation, viruses and bacteria trigger acute pulmonary exacerbations, accelerating disease progression and mortality rate. Treatment complexity increases with patients’ age, and simplifying the therapeutic regimen represents one of the key priorities in CF. We have recently reported the discovery of multitarget compounds able to “kill two birds with one stone” by targeting F508del-CFTR and PI4KIIIβ and thus acting simultaneously as CFTR correctors and broad-spectrum enterovirus (EV) inhibitors. Starting from these preliminary results, we report herein a hit-to-lead optimization and multidimensional structure–activity relationship (SAR) study that led to compound 23a. This compound showed good antiviral and F508del-CFTR correction potency, additivity/synergy with lumacaftor, and a promising in vitro absorption, distribution, metabolism, and excretion (ADME) profile. It was well tolerated in vivo with no sign of acute toxicity and histological alterations in key biodistribution organs
Autologous heterotopic transplant of the thyroid in man: functional and clinical study after twenty-four years
Cardiovascular, baroreflex and humoral responses in hypertensive patients during nicardipine therapy
Renin-aldosterone system suppression during water immersion in renovascular hypertension
Human Vitronectin-Derived Peptide Covalently Grafted onto Titanium Surface Improves Osteogenic Activity: A Pilot In Vivo Study on Rabbits
Peptide and protein exploitation for the biochemical functionalization of biomaterial surfaces allowed fabricating
biomimetic devices able to evoke and promote specific and advantageous cell functions in vitro and in vivo. In
particular, cell adhesion improvement to support the osseointegration of implantable devices has been thoroughly
investigated. This study was aimed at checking the biological activity of the (351\u2013359) human vitronectin precursor
(HVP) sequence, mapped on the human vitronectin protein; the peptide was covalently linked to the
surface of titanium cylinders, surgically inserted in the femurs of New Zealand white rabbits and analyzed at short
experimental time points (4, 9, and 16 days after surgery). To assess the osteogenic activity of the peptide, three
vital fluorochromic bone markers were used (calcein green, xylenol orange, and calcein blue) to stain the areas of
newly grown bone. Static and dynamic histomorphometric parameters were measured at the bone\u2013implant
interface and at different distances from the surface. The biological role of the (351\u2013359)HVP sequence was
checked by comparing peptide-grafted samples and controls, analyzing how and how much its effects change
with time across the bone regions surrounding the implant surface. The results obtained reveal a major activity of
the investigated peptide 4 days after surgery, within the bone region closest to the implant surface, and larger bone
to implant contact 9 and 16 days after surgery. Thus, improved primary fixation of endosseous devices can be
foreseen, resulting in an increased osteointegration
Studio istomorfometrico dell'attivit\ue0\ua0 osteogenica indotta dalla funzionalizzazione del titanio con il peptide HVP(351-359)
Effetti di un trattamento con un’acqua minerale bicarbonato-alcalino-terrosa sulla lattacidemia in cirrotici
- …